Tag Archives: Aphria

Shoppers Drug Mart Marijuana Closer to Reality With Second Supplier Named

Shoppers Drug Mart Marijuana Closer to Reality With Second Supplier Named

Shoppers Drug Mart Marijuana Closer to Reality With Second Supplier Named

Shoppers Drug Mart marijuana is one step closer to reality after a public Canadian marijuana company announced that it has signed on to be the Canadian pharmacy chain’s second medical marijuana supplier.

Aphria Stock Soars Following Announcement of Medical Cannabis Deal With Shoppers Drug Mart

Aphria Stock Soars After Announcement of Cannabis Deal With Shoppers Drug Mart

Following market close on Dec. 4, 2017, Aphria Inc. (TSX:APH), an Ontario-based licensed producer of medical cannabis, made headlines when it announced that it had entered into an agreement to be the medical cannabis supplier for Shoppers Drug Mart, a Canadian pharmacy chain.

Canada Weed Stocks Come Off High as Challenges Loom Before Legalization

Canada Weed Stocks Come Off High as Challenges Loom Before Legalization

Canada’s weed stocks, which have surrendered some of the potent gains that pushed them to record highs this month, face a bumpy ride in 2018 that could purge smaller players, as the country moves to allow recreational use of cannabis in July.

share purchase

Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria

OTTAWA, Ontario Nov. 16, 2017 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx Princeps(TM), unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. (“Aphria”) under Access to Cannabis for Medical Purposes Regulations (ACMPR).

share purchase

Tetra Bio-Pharma Hires Medical Science Liaison to Promote Rx Princeps(TM) and Presents its New Corporate Image

OTTAWA, Oct. 19, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced the hiring of Dr. Vincent Jourdain, Ph. D. as medical science liaison (MSL).

share purchase

Tetra Bio-Pharma Signs Agreement with Partner Aphria to Start Promoting Rx Princeps(TM), its Medical Cannabis Blend, under ACMPR

OTTAWA, Ontario, Oct. 18, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that it will start promoting a co-developed medical cannabis blend product under Access to Cannabis for Medical Purposes Regulations (ACMPR).

Survey: Canadian Cannabis Salaries on Par With Other Industries in Country

Survey: Canadian Cannabis Salaries on Par With Other Industries in Country

The legalization of recreational cannabis in Canada has the country preparing for unprecedented expansion and with that will undoubtedly come career opportunities, but what can job seekers expect in regards to Canadian cannabis salaries?

Should Investors Avoid Canadian Marijuana Producers With U.S. Assets?

Should Investors Avoid Canadian Marijuana Producers With U.S. Assets?

TMX Group Ltd. (TSX:X), the operator of the Toronto Stock Exchange (TSX) and TSX Venture Exchange (TSXV), has reportedly been speaking with regulators to figure out what will happen to Canadian marijuana producers with assets in the U.S.

Flickr / Jen Montgomery / (CC BY-NC-ND 2.0)

The Average Marijuana Stock Is Up 332% Over the Past Year

Over the trailing-12-month period through July 15, the average marijuana stock with a market cap in excess of $200 million — a dozen stocks in total, which excluded MedReleaf because it just went public a month ago — was up by 332%.

The Very First Cannabis Stock ETF Is Now in Bear-Market Territory

The Very First Cannabis Stock ETF is Now in Bear-Market Territory

The first cannabis stock ETF of its kind, the Horizons Marijuana Life Sciences Index ETF allows investors to own more than a dozen pot stocks through a single investment fund. Today, however, is a different story.

Say Hello to the Largest North American Marijuana Stock IPO

Say Hello to the Largest North American Marijuana Stock IPO

In April, investors were privy to the very first marijuana stock ETF, which debuted on the Toronto Stock Exchange with slightly more than a dozen holdings. This represented the very first time a basket fund was created for investors to easily diversify their pot-stock holdings. And last week, investors witnessed another marijuana first: the largest North American marijuana stock IPO of all-time.

Canadian Cannabis Investors Bogart Deals in America

Canadian Cannabis Investors Bogart Deals in America

There is so much Canadian cannabis investment money right now that it is cascading down into the United States and Canadian investors are easily outbidding domestic acquirers.

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

Which Cannabis Stock Could Be First to $1 Billion in Annual Sales?

If there is a “Holy Grail” milestone out there for cannabis stocks, it’s the $1 billion sales mark. The first cannabis company to hit $1 billion in sales will likely validate the industry to Wall Street and investors. But which marijuana stock has the best chance at being first to $1 billion in annual sales?

Better Know a Marijuana Stock: Canopy Growth Corp.

Better Know a Marijuana Stock: Canopy Growth Corp.

A major Canadian medical marijuana player, Canopy Growth is a producer and retailer of medical cannabis products and oils in our neighbor to the north. It’s also the only other marijuana stock other than GW Pharmaceuticals to bear a $1 billion valuation.

Aphria

Aphria Launches US Expansion Strategy

LEAMINGTON, Ontario, April 4, 2017 /Weed Wire/ – Aphria Inc. (“Aphria” or the “Company”) (TSX:APH)(OTCQB:APHQF) is pleased to announce the launch of its US expansion strategy through a strategic lead investment in an entity to be renamed Liberty Health Sciences Inc. (“Liberty”) that will operate in the United States under the brand “Aphria USA”.

Aphria

Aphria Strengthens US Investment Platform, Increases Position in Copperstate Farms Investors to 18.5%

LEAMINGTON, Ontario, March 27, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX:APH)(OTCQB:APHQF), through its subsidiary Aphria (Arizona) Inc., is pleased to announce that it made an additional investment of $3 million (USD) in Copperstate Farms Investors, LLC (“Investors”).

Aphria

Aphria Continues Success Story With TSX Listing

LEAMINGTON, Ontario, March 21, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF), a Health Canada Licensed Producer of medical cannabis products, today announced that the common shares (the “Common Shares”) of the Company will begin trading on the Toronto Stock Exchange (“TSX”) as of the open of the market on March 22, 2017.

Top 5 States for Marijuana Stocks

Top 5 States for Marijuana Stocks

Over the next five years, the U.S. marijuana market could be worth tens of billions of dollars, and according to GreenWave Advisors, LLC, these five states could move the needle most for marijuana companies. Learn just how big the marijuana market may be in California, Washington, Pennsylvania, Colorado, and Michigan in 2021.

Aphria

Aphria Receives Conditional Approval to Graduate to the TSX

LEAMINGTON, Ontario, Feb. 6, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange and list its common shares on the TSX.

Aphria

Aphria’s Vision to be Reality – Part IV Expansion Project to Increase Greenhouse Growing Space to 1 Million Square Feet

LEAMINGTON, Ontario, Jan. 16, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that its Board approved a $137 million capital project, known internally as Part IV expansion.

Aphria

Aphria Continues Expansion Strategy

LEAMINGTON, Ontarion, Dec. 14, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company entered into a purchase and sale agreement to acquire 200 acres of fully serviced vacant land for $6.24 million located at 521 Mersea Road 8, Leamington, Ontario.

Aphria

Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials

OTTAWA, Ontario, Dec. 6, 2016 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra Bio” or “the Company”) (OTC PINK:GRPOF) is conducting a non-brokered private placement with Aphria Inc. (OTCQB:APHQF).

MassRoots Users Funding Round and Crosses Half a Million Users and NASDAQ

MassRoots Completes $5.0 Million Equity Financing

DENVER, Oct. 21, 2016 /Weed Wire/ — MassRoots, Inc. (OTCQB: MSRT), one of the leading technology platforms for the cannabis industry, is pleased to announce it has completed a $5.0 million equity offering under its Registration Statement, declared effective by the Securities and Exchange Commission on August 11, 2016.

massroots_aphria_combo

Aphria and MassRoots Partner in One of First International Collaborations between Cannabis Companies

LEAMINGTON, Ontario, Oct. 18,2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX-V: APH or USOTCQB: APHQF) one of the leading Canadian licensed producers of medical cannabis, and MassRoots, Inc. (OTCQB:MSRT), one of the largest technology platforms for the cannabis industry, are pleased to announce they have entered into one of the first international partnerships between cannabis companies.

Aphria

Aphria Announces Licence Amendment

LEAMINGTON, Ontario, Sept. 26, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced an amendment to is licence by Health Canada, allowing it to grow up to 3,600 kilograms of dried cannabis and to sell up to 2,800 kilograms of dried cannabis, over the next year.

Aphria

Aphria Finalizes Licensing Deal With Tokyo Smoke

TORONTO, Ontario, Sept. 19, 2016 /Weed Wire/ — Aphria Inc. (“Aphria”) (TSX VENTURE:APH)(OTCQB:APHQF), in connection with its previously announced licensing deal with Tokyo Smoke, a premium cannabis-oriented lifestyle brand, has issued to Tokyo Smoke 38,759 common shares of Aphria and 200,000 common share purchase warrants exercisable for a period of 5 years at an exercise price of $3.14 per warrant.

Aphria

Aphria to Triple Its Production Space as it Starts Part III Expansion

LEAMINGTON, Ontario, Sept.16,2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce that its Board of Directors approved a fully funded $24.5 million capital project as the first phase of its Part III expansion.

Aphria

Aphria Partners With Leading International Consumer Lifestyle Brand Tokyo Smoke

TORONTO, Sept. 7, 2016 /Weed Wire/ — Today Aphria Inc. (“Aphria”) (TSX VENTURE:APH) (OTCQB:APHQF), one of Canada’s leading licensed producers of medical cannabis, announced a groundbreaking licensing deal with Tokyo Smoke, a premium cannabis-oriented lifestyle brand.

MedLab LTD

Medlab and Aphria Complete Cannabis Supply Deal Ahead of Cannabis Human Trial

LEAMINGTON, Ontario, Aug. 22, 2016 /Weed Wire/ — Medical life science company, Medlab Clinical Limited (ASX:MDC), has signed a significant cannabis supply agreement with Canadian licenced producer of medical marijuana, Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF).

Aphria

Aphria Accelerates Expansion Strategy

LEAMINGTON, Ontario, Aug. 19, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company entered into a purchase and sale agreement with DiNiro Farms Inc. (“DiNiro”) to acquire 11 acres of additional property adjacent to its existing campus for a $2.1 million cash payment.


Page 1 of 212
Top